A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2016.07.041

PubMed Identifier: 27477844

Publication URI: http://europepmc.org/abstract/MED/27477844

Type: Journal Article/Review

Parent Publication: Vaccine

Issue: 38

ISSN: 0264-410X